Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
Achondroplasia (ACH) is a disorder of the genes. The changes in the genes causes short stature and a large head. It is the most common cause of dwarfism.
People with ACH reach a full-grown height of around 4-4½ feet. The arm bone between the shoulder and the elbow and the leg bone between the hip and the knee are most affected. It may also affect how the face develops.
ACH is caused by a change in the FGFR3 gene. This gene controls how bones and cartilage grow. A defect in the gene prevents normal growth and leads to shorter and abnormally shaped bones.
The defect can occur suddenly, for no known reason. It early in pregnancy when the sperm and egg meet. The gene can also be passed through a family, though this is less common. If a parent has the defective gene, there is a 50% chance the child will have it. You can carry the gene and not have ACH.
Factors that may increase the chance of ACH include:
Characteristics of ACH include:
Other common symptoms include:
Signs of ACH may be visible during prenatal testing. If the doctor suspects ACH, other tests may be recommended. An amniocentesis can remove a small amount of fluid from around the baby. Genetic testing can be done to confirm ACH.
After birth, the doctor will do a physical exam. Images of the bones may be taken with:
A genetic counselor can help you understand the risk of having a child with ACH. You may consider it if you have a family history or you know you have the altered gene.
At this time, there is no cure for ACH. The goal of treatment is to manage related health issues. The child's care team with check for common issues such as:
Copyright © Nucleus Medical Media, Inc.
Regular appointments will help to find any problems early. Early treatment may improve outcomes. General treatments may include:
Human growth hormone may help to increase adult height. It is given during childhood.
Surgery is sometimes needed to correct some bone deformities. Some common options include:
There are no steps to prevent ACH. The change in the gene appears random.
Healthy Children—American Academy of Pediatrics
Little People of America
Caring for Kids—Canadian Paediatrics Society
Little People of Ontario
Achondroplasia. EBSCO Plus DynaMed website. Available at:http://www.dynamed.com/topics/dmp~AN~T114336/Acute-intestinal-pseudo-obstruction. Updated December 3, 2018. Accessed December 3, 2018.
Aldegheri R, Dall'Oca C. Limb lengthening in short stature patients. J Pediatr Orthop B. 2001;10(3):238-247.
Aviezer D, Golembo M, Yayon A. Fibroblast growth factor receptor-3 as a therapeutic target for achondroplasia—genetic short limbed dwarfism. Curr Drug Targets. 2003;4(5):353-65.
Last reviewed March 2018 by EBSCO Medical Review Board James P. Cornell, MD Last Updated: 12/11/2018